CD4+ T cells and CD8+ T cells-mediated immune responses are present throughout the course of COVID-19 disease, but evidence of CD4+ T cells and CD8+ T cells in COVID-19 disease surveillance is still lacking in large samples. The gene discussed is CD4; the disease is COVID-19.